Publications by authors named "Annette Pluetschow"

Claim this Profile
J
JAK inhibition with ruxolitinib in relapsed or refractory classical Hodgkin lymphoma: Final results of a phase II, open label, multicentre clinical trial (JeRiCHO).
Sarah Gillessen, Annette Pluetschow, Vladan Vucinic, Helmut Ostermann, Carsten Kobe

Eur J Haematol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the first COVID-19 lockdown in Germany on the rate of acute infections during intensive chemotherapy for Hodgkin lymphoma.
Anne Sophie Jacob, Helen Kaul, Michael Fuchs, Sarah Gillessen, Stefanie Kreissl, Annette Pluetschow

Infection· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ABVD in older patients with early-stage Hodgkin lymphoma treated within the German Hodgkin Study Group HD10 and HD11 trials.
Boris Böll, Helen Görgen, Michael Fuchs, Annette Pluetschow, Hans Theodor Eich

J Clin Oncol· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 study of rituximab in newly diagnosed stage IA nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group.
Dennis A Eichenauer, Michael Fuchs, Annette Pluetschow, Beate Klimm, Teresa Halbsguth

Blood· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis